Insulin Signaling Defects in Type 2 Diabetes
- 1 May 2004
- journal article
- review article
- Published by Springer Nature in Reviews in Endocrine and Metabolic Disorders
- Vol. 5 (2) , 111-117
- https://doi.org/10.1023/b:remd.0000021432.84588.f6
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Rosiglitazone Improves Downstream Insulin Receptor Signaling in Type 2 Diabetic PatientsDiabetes, 2003
- Peroxisome proliferator‐activated receptors (PPARS): regulators of gene expression in heart and skeletal muscleActa Physiologica Scandinavica, 2003
- Defective Signaling Through Akt-2 and -3 But Not Akt-1 in Insulin-Resistant Human Skeletal MuscleDiabetes, 2003
- A Method to Identify Serine Kinase SubstratesJournal of Biological Chemistry, 2002
- Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients.Diabetes, 2000
- Protein Kinase C Isotypes Controlled by Phosphoinositide 3-Kinase Through the Protein Kinase PDK1Science, 1998
- Phosphoinositide 3-kinase: the key switch mechanism in insulin signallingBiochemical Journal, 1998
- Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1992
- Defective insulin receptor tyrosine kinase in human skeletal muscle in obesity and Type 2 (non-insulin-dependent) diabetes mellitusDiabetologia, 1987
- Insulin receptor kinase in human skeletal muscle from obese subjects with and without noninsulin dependent diabetes.Journal of Clinical Investigation, 1987